Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuous ECG Monitoring Data Collection Study in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Performance of the Cara Monitor Conduction Disturbance Risk Score (CDRS).

NCT05657912 is registered in ClinicalTrials.gov with Cara Medical Ltd as lead sponsor.

NCT NCT05657912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05657912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuous ECG Monitoring Data Collection Study in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Performance of the Cara Monitor Conduction Disturbance Risk Score (CDRS).
Lead sponsor
Cara Medical Ltd
Phase
Observational
Overall status
Completed
Start date
December 12, 2022
Completion date
May 31, 2025
Enrollment
355 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve replacement